1-4 of 4
mandibular advancement
Close
Sort by
Journal Articles

Evolution of Moderate Aplastic Anemia into Subclinical PNH/AA and Successful Treatment with Reduced Intensity Haplo-HSCT: A Pediatric Case Report

Meghana Srinivas, Jennifer Krajewski, MD, Nancy Durning, APN, Melanie Hankewycz, APN, Alfred Gillio, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5027.
https://doi.org/10.1182/blood-2019-130407
Published: 2019
Journal Articles

Clinical and Molecular Heterogeneity of Moderate Aplastic Anemia

Bhumika J. Patel, MD, Shimoli Vipul Barot, MD, Teodora Kuzmanovic, BA, Bartlomiej P. Przychodzen, Cassandra M. Hirsch, Hassan Awada, MD, Metis Hasipek, PhD, Swapna Thota, MD, Tomas Radivoyevitch, PhD, Anjali S. Advani, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD MS, Hetty E. Carraway, MD MBA, Jaroslaw P. Maciejewski
Journal: Blood
Blood (2018) 132 (Supplement 1): 2590.
https://doi.org/10.1182/blood-2018-99-119852
Published: 2018
Journal Articles

Markers of Responsiveness to ATG/CsA Therapy in Patients with Severe Aplastic Anemia.

Abdo S. Haddad, MD, Ania Jankowska, Theodore Ghazal, Sandra Smieszek, Ramon Tiu, MD, Matt Kalaycio, MD, Jarek P. Maciejewski, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1699.
https://doi.org/10.1182/blood.V110.11.1699.1699
Published: 2007
Journal Articles

Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia

Brief Report
Jaroslaw P. Maciejewski, Elaine M. Sloand, Olga Nunez, Carol Boss, Neal S. Young
Journal: Blood
Blood (2003) 102 (10): 3584–3586.
https://doi.org/10.1182/blood-2003-04-1032
Published: 2003